Japan · Delayed Price · Currency is JPY K Pharma,Inc. Statistics
Total Valuation
K Pharma,Inc. has a market cap or net worth of JPY 7.99 billion. The enterprise value is 6.48 billion.
| Market Cap | 7.99B |
| Enterprise Value | 6.48B |
Important Dates
The next estimated earnings date is Thursday, February 12, 2026.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
K Pharma,Inc. has 11.61 million shares outstanding. The number of shares has increased by 0.62% in one year.
| Current Share Class | 11.61M |
| Shares Outstanding | 11.61M |
| Shares Change (YoY) | +0.62% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 43.07% |
| Owned by Institutions (%) | 3.04% |
| Float | 1.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 5.07 |
| P/TBV Ratio | 5.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.18 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 22.40
| Current Ratio | 22.40 |
| Quick Ratio | 20.60 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -44.53% and return on invested capital (ROIC) is -3,608.16%.
| Return on Equity (ROE) | -44.53% |
| Return on Assets (ROA) | -25.81% |
| Return on Invested Capital (ROIC) | -3,608.16% |
| Return on Capital Employed (ROCE) | -54.91% |
| Weighted Average Cost of Capital (WACC) | 4.04% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -53.12M |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, K Pharma,Inc. has paid 3.00 million in taxes.
| Income Tax | 3.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.46% in the last 52 weeks. The beta is -0.04, so K Pharma,Inc.'s price volatility has been lower than the market average.
| Beta (5Y) | -0.04 |
| 52-Week Price Change | +3.46% |
| 50-Day Moving Average | 668.50 |
| 200-Day Moving Average | 703.04 |
| Relative Strength Index (RSI) | 50.01 |
| Average Volume (20 Days) | 47,260 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -884.00M |
| Pretax Income | -900.00M |
| Net Income | -903.00M |
| EBITDA | n/a |
| EBIT | -884.00M |
| Earnings Per Share (EPS) | -77.81 |
Balance Sheet
The company has 1.50 billion in cash and n/a in debt, with a net cash position of 1.50 billion or 129.55 per share.
| Cash & Cash Equivalents | 1.50B |
| Total Debt | n/a |
| Net Cash | 1.50B |
| Net Cash Per Share | 129.55 |
| Equity (Book Value) | 1.58B |
| Book Value Per Share | 135.81 |
| Working Capital | 1.56B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
K Pharma,Inc. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.62% |
| Shareholder Yield | -0.62% |
| Earnings Yield | -11.31% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |